Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,572 | 207,075 | 247,796 | 498,925 | 237,876 |
| Marketable Securities | 136,796 | 134,255 | 226,954 | 267,532 | 221,400 |
| Receivables | 81,917 | 65,568 | 35,212 | 18,320 | 7,493 |
| TOTAL | $357,622 | $425,508 | $521,442 | $797,829 | $469,984 |
| Non-Current Assets | |||||
| PPE Net | 347,450 | 259,676 | 142,035 | 58,304 | 49,353 |
| Investments And Advances | 370,053 | 47,080 | 51,061 | 78,222 | 61,983 |
| Other Non-Current Assets | 14,307 | 8,938 | 9,682 | 1,903 | 3,770 |
| TOTAL | $731,810 | $315,694 | $202,778 | $138,429 | $115,106 |
| Total Assets | $1,089,432 | $741,202 | $724,220 | $936,258 | $585,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 53,658 | 49,031 | 36,168 | 39,232 | 21,471 |
| TOTAL | $109,056 | $93,575 | $83,672 | $283,664 | $45,014 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 200,000 |
| Deferred Revenues | 54,723 | 44,544 | 47,504 | 44,432 | 23,543 |
| Other Non-Current Liabilities | 7,350 | 3,959 | 2,431 | 0 | 0 |
| TOTAL | $452,561 | $250,865 | $219,034 | $192,327 | $323,452 |
| Total Liabilities | $561,617 | $344,440 | $302,706 | $475,991 | $368,466 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,959 | 81,653 | 79,977 | 78,985 | 65,631 |
| Common Shares | 89 | 79 | 80 | 79 | 65 |
| Retained earnings | -1,045,563 | -941,095 | -873,265 | -793,217 | -687,617 |
| Other shareholders' equity | -2,491 | 1,046 | -114 | 170 | -231 |
| TOTAL | $527,815 | $396,762 | $421,514 | $460,267 | $216,624 |
| Total Liabilities And Equity | $1,089,432 | $741,202 | $724,220 | $936,258 | $585,090 |